UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006393
Receipt number R000007568
Scientific Title Cross-sectional study of second-line therapy administration after platinum-based chemotherapy for patients with advanced NSCLC.
Date of disclosure of the study information 2011/09/22
Last modified on 2020/08/19 13:55:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cross-sectional study of second-line therapy administration after
platinum-based chemotherapy for patients with advanced NSCLC.

Acronym

Second-line chemotherapy administration for patients with advanced NSCLC, who completed platinum-based "Hyojun" (standard) doublet, In the follow-up period, and at recurrence.(SAPPHIRE)

Scientific Title

Cross-sectional study of second-line therapy administration after
platinum-based chemotherapy for patients with advanced NSCLC.

Scientific Title:Acronym

Second-line chemotherapy administration for patients with advanced NSCLC, who completed platinum-based "Hyojun" (standard) doublet, In the follow-up period, and at recurrence.(SAPPHIRE)

Region

Japan


Condition

Condition

Advanced lung cancer

Classification by specialty

Pneumology Hematology and clinical oncology Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the proportion of the second-line therapy administration after platinum-based chemotherapy for patients with advanced NSCLC, and explore the reasons and the background factors of the patients who could not take the second-line therapy. We also discuss the strategy for the follow-up of patients after the first-line chemotherapy (maintenance chemotherapy, periodical follow-up without continuing chemotherapy), by comparing the background factors at the beginning of the first and second line chemotherapy.

Basic objectives2

Others

Basic objectives -Others

horyuu

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Proportion of the patients administered the second-line chemotherapy

Key secondary outcomes

1)Proportion of the patients who had PD for first-line chemotherapy
2)Proportion of the patients who were administered second-line chemotherapy
3)Proportion of the patients who were administered third-line chemotherapy after the second-line chemotherapy
4)Proportion of the patients who were administered second-line chemotherapy after having PD for first-line chemotherapy.
5)Proportion of the patients who were administered second-line chemotherapy after taking maintenance chemotherapy.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients who were diagnosed as advanced or recurrent NSCLC before this study.
2)Consecutive patients in each institution who had started first-line platinum chemotherapy in combination with third generation agent after April 1, 2010.

Key exclusion criteria

1)Recurrent NSCLC patients who had undergone adjuvant platinum based chemotherapy.
2)Active double cancer.

Target sample size

750


Research contact person

Name of lead principal investigator

1st name Hideo
Middle name
Last name Kunitoh

Organization

Mitsui Memorial Hospital

Division name

Department of Respiratory Medicine

Zip code

101-8643

Address

1,Kanndaizumi-chou, Chiyoda-ku, Tokyo, 101-8643, Japan

TEL

03-3862-9111

Email

no@mail


Public contact

Name of contact person

1st name Akira
Middle name
Last name Yamao

Organization

Public Health Research Foundation

Division name

Comprehensive Support Project for Clinical Research

Zip code

169-0051

Address

1-1-7, Nishiwaseda, Shinjuku-ku, Tokyo, 169-0051, Japan

TEL

03-5287-2633

Homepage URL

http://www.csp.or.jp/

Email

info@csp.or.jp


Sponsor or person

Institute

SAPPHIRE Executive committee

Institute

Department

Personal name



Funding Source

Organization

Public Health Research Foundation

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

no

Address

no

Tel

no

Email

nomail


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 09 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2010 Year 09 Month 03 Day

Date of IRB


Anticipated trial start date

2010 Year 10 Month 01 Day

Last follow-up date

2013 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

horyuu


Management information

Registered date

2011 Year 09 Month 22 Day

Last modified on

2020 Year 08 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007568


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name